Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
1.30
May. 08, 2025 16:00:00- Change -0.07 (-5.10949%)
- Volume 218,623
- Today's Open 1.41
- Previous Close 1.37
- Today's High 1.41
- Today's Low 1.28
- 52 Week High 4.3
- 52 Week Low 1.27